MCID: HMN010
MIFTS: 60

Hemangioma malady

Categories: Genetic diseases (common), Cancer diseases

Aliases & Classifications for Hemangioma

About this section

Summaries for Hemangioma

About this section
Disease Ontology:11 A cell type benign neoplasm that has physical basis in endothelial cells that line blood vessels and is characterised by increased number of normal or abnormal vessels filled with blood.

MalaCards based summary: Hemangioma is related to hemangioma, capillary infantile and pituitary adenoma. An important gene associated with Hemangioma is KDR (Kinase Insert Domain Receptor), and among its related pathways are VEGF binds to VEGFR leading to receptor dimerization and Signaling events mediated by VEGFR1 and VEGFR2. The drugs peginterferon alfa-2b and interferon alfacon-1 have been mentioned in the context of this disorder. Affiliated tissues include liver, endothelial and lung, and related mouse phenotypes are no phenotypic analysis and embryo.

Wikipedia:71 An infantile hemangioma (IH) is one of the most common benign tumors of infancy and occurs in... more...

Related Diseases for Hemangioma

About this section

Diseases in the Hemangioma family:

Acquired Hemangioma Hemangioma, Hereditary
Familial Hemangioma

Diseases related to Hemangioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 457)
idRelated DiseaseScoreTop Affiliating Genes
1hemangioma, capillary infantile34.0ANTXR1, FLT4, KDR
2pituitary adenoma29.5KDR, NKX2-1, SFTPB
3renal cell carcinoma29.2FGF2, FLT4, KDR, KRAS, NKX2-1, SLC2A1
4hemangioblastoma28.6CD34, FGF2, PDPN, SLC2A1, TEK
5hematopoietic stem cell transplantation27.4ANTXR1, CD34, FGF2, FLT4, KDR, KRAS
6capillary hemangioma12.2
7cavernous hemangioma12.2
8sclerosing hemangioma12.1
9rapidly involuting congenital hemangioma12.0
10hemangioma-thrombocytopenia syndrome12.0
11non-involuting congenital hemangioma12.0
12glomeruloid hemangioma12.0
13intramuscular hemangioma11.9
14pulmonary sclerosing hemangioma11.8
15giant hemangioma11.8
16spindle cell hemangioma11.8
17histiocytoid hemangioma11.8
18skin hemangioma11.8
19venous hemangioma11.8
20hemangioma of spleen11.8
21hobnail hemangioma11.8
22hemangioma of liver11.8
23gastric hemangioma11.8
24hemangioma of lung11.8
25acquired hemangioma11.8
26supraumbilical midabdominal raphe and facial cavernous hemangiomas11.8
27verrucous hemangioma11.8
28breast hemangioma11.8
29bone epithelioid hemangioma11.8
30diffuse cavernous hemangioma of the rectum11.7
31hemangioma of orbit11.7
32cavernous hemangioma of orbit11.7
33hemangioma, hereditary11.7
34intracranial structure hemangioma11.7
35hemangioma of intra-abdominal structure11.7
36central nervous system hemangioma11.7
37hemangioma of subcutaneous tissue11.6
38skin epithelioid hemangioma11.6
39verrucous keratotic hemangioma11.6
40cavernous hemangioma of colon11.6
41breast epithelioid hemangioma11.6
42hemangiomas, cavernous, of face and supraumbilical midline raphe11.6
43breast capillary hemangioma11.6
44sacral hemangiomas multiple congenital abnormalities11.6
45hemangioma, capillary infantile susceptibility11.6
46congenital liver hemangioma11.6
47pyogenic granuloma11.6
48cerebral cavernous malformations-111.6
49angioma, hereditary neurocutaneous spinal arterial venous malformations with cutaneous hemangiomas, included11.6
50hemangioma of peripheral nerve11.6

Graphical network of the top 20 diseases related to Hemangioma:



Diseases related to hemangioma

Symptoms & Phenotypes for Hemangioma

About this section

MGI Mouse Phenotypes related to Hemangioma according to GeneCards Suite gene sharing:

41 (show all 17)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00030129.3ANTXR1, FLT4, KDR, KRAS, NKX2-1, SLC2A1
2MP:00053808.9ANGPT1, FLT4, KDR, KRAS, KRIT1, SLC2A1
3MP:00020068.9ANTXR1, CD34, FGF2, KRAS, KRIT1, NKX2-1
4MP:00028738.8ACTC1, FLT4, KDR, KRAS, NKX2-1, PROX1
5MP:00053708.8DIO3, FLT4, KDR, KRAS, PECAM1, PROX1
6MP:00053888.3ANGPT2, KDR, KRAS, NKX2-1, PDPN, PECAM1
7MP:00107718.3ANGPT2, CD34, FLT4, KDR, KRAS, KRIT1
8MP:00053918.3ANGPT1, ANGPT2, FGF2, KDR, KRAS, KRIT1
9MP:00053818.2ANGPT2, FLT4, KRAS, NKX2-1, PDPN, PECAM1
10MP:00053697.6ACTC1, ANGPT1, FGF2, FLT4, KDR, KRAS
11MP:00053977.0CD34, FGF2, KDR, KRAS, LYVE1, PDPN
12MP:00053876.5ANGPT1, ANGPT2, ANTXR1, CD34, FLT4, KDR
13MP:00053786.4ACTC1, ANGPT1, ANTXR1, DIO3, FLT4, KDR
14MP:00053846.1ACTC1, ANGPT2, ANTXR1, CD34, DIO3, FGF2
15MP:00107685.6ACTC1, ANGPT1, ANGPT2, ANTXR1, DIO3, FGF2
16MP:00053855.2ACTC1, ANGPT1, ANGPT2, ANTXR1, FGF2, FLT4
17MP:00053765.1ACTC1, ANGPT1, ANGPT2, CD34, DIO3, FGF2

Drugs & Therapeutics for Hemangioma

About this section

Drugs for Hemangioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 208)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1ParecoxibapprovedPhase 439198470-84-7
2
Sufentanilapproved, investigationalPhase 417556030-54-741693
Synonyms:
56030-54-7
60561-17-3 (citrate)
AC1L26AJ
AC1Q5I7B
C08022
C22H30N2O2S
CHEBI:127638
CHEBI:9316
CHEMBL658
CID41693
Chronogesic
D05938
DB00708
HSDB 6760
L000580
LS-175693
MolPort-004-286-008
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide
 
N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide
N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide
Oprea1_120838
Oprea1_246787
PDSP1_001741
PDSP2_001724
R 30730
R-30730
SUFENTANIL
Sufentanil
Sufentanil (USAN/INN)
Sufentanil Citrate
Sufentanil [USAN:BAN:INN]
Sufentanilo
Sufentanilum
Sufentanilum [INN-Latin]
Sufentanyl
Sulfentanil
Sulfentanyl
UNII-AFE2YW0IIZ
3
Methylprednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
4
Propranololapproved, investigationalPhase 4, Phase 2, Phase 3, Phase 1216525-66-64946
Synonyms:
(+-)-Propranolol
(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol
(R)-(+)-propranolol
(S)-(-)-PROPRANOLOL
1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol
1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol
1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol
13013-17-7
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)- (9CI)
3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol
4199-09-1
4199-10-4
525-66-6
AB00053537
AC1L1JA4
AC1Q1QBV
AC1Q1QC0
AKOS000588816
AY 64043
AY-20694
Anaprilin
Anapriline
Angilol
Apsolol
Avlocardyl
BPBio1_001040
BRD-A10070317-003-06-9
BSPBio_000944
BSPBio_002682
Bedranol
Beprane
Berkolol
Beta Neg
Beta-Neg
Beta-Propranolol
Beta-Tablinen
Beta-Timelets
Betachron
Betadren
Betalong
Bio-0732
Bio1_000367
Bio1_000856
Bio1_001345
C07407
C16H21NO2
CBDivE_006180
CCRIS 3082
CHEBI:8499
CHEMBL27
CID4946
Cardinol
Caridolol
Corpendol
D,L-Propranolol
D08443
DB00571
DL-Propranolol hydrochloride
Deralin
DivK1c_000023
Dl-Propranolol Hydrochloride
Dociton
Duranol
EINECS 208-378-0
EINECS 235-867-6
Efektolol
Elbrol
Etalong
Euprovasin
Frekven
HMS2090L21
Herzbase
ICI 45520
IDI1_000023
INDERIDE-40/25
INDERIDE-80/25
Ikopal
Inderal
Inderal La
Inderal hydrochloride
Inderalici
Inderex
Inderide
Inderol
Indobloc
InnoPranXL
 
Innopran XL
Intermigran
KBio1_000023
KBio2_002515
KBio2_005083
KBio2_007651
KBio3_001766
KBio3_001902
KBio3_002993
KBioGR_001347
KBioGR_001684
KBioGR_002515
KBioSS_002523
Kemi
Kemi S
L000679
LS-122410
LS-184129
Lopac0_000896
Migrastat
MolPort-001-794-623
NCGC00015798-07
NCGC00024690-02
NCGC00024690-03
NINDS_000023
NSC91523
Naprilin
Obsidan
Obzidan
Oposim
Oprea1_304193
PDSP1_000767
PDSP1_001607
PDSP1_001608
PDSP2_000755
PDSP2_001591
PDSP2_001592
Prano-Puren
Pranolol
Prestwick0_000952
Prestwick1_000952
Prestwick2_000952
Prestwick3_000952
Pronovan
Propanalol
Propanix
Propanolol
Propanolol [INN-Spanish]
Prophylux
Propranalol
Propranolol
Propranolol (INN)
Propranolol (TN)
Propranolol Hcl
Propranolol Hcl Intensol
Propranolol Hydrochloride
Propranolol [INN:BAN]
Propranololo
Propranololo [DCIT]
Propranololum
Propranololum [INN-Latin]
Propranur
Proprasylyt
Pylapron
R,S-Propranolol Hydrochloride
Racemic propranolol
Rapynogen
Reducor
Reducor Line
Reducor line
SPBio_001361
SPBio_001658
SPBio_003093
STK735510
Sagittol
Sawatal
Servanolol
Sloprolol
Spectrum2_001301
Spectrum2_001699
Spectrum3_000883
Spectrum3_001071
Spectrum4_000974
Spectrum4_001222
Spectrum5_000751
Sumial
Tesnol
UNII-9Y8NXQ24VQ
b-Propranolol
beta-Propranolol
cMAP_000071
etalong
propranolol
propranololo
β-Propranolol
5
Prednisoloneapproved, vet_approvedPhase 4, Phase 3, Phase 2115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
6
Dexmedetomidineapproved, vet_approvedPhase 454076631-46-4, 113775-47-668602, 5311068, 56032
Synonyms:
(+)-4-((S)-alpha,2,3-Trimethylbenzyl)imidazole
(+)-4-((S)-alpha,2,3-trimethylbenzyl)imidazole
(+)-medetomidine
(S)-medetomidine
113775-47-6
4-[(1S)-1-(2,3-Dimethylphenyl)ethyl]-1H-imidazole
4-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole
AC1NSJXT
C07450
CHEBI:4466
CHEMBL778
CID5311068
D00514
DEXMEDETOMIDINE
 
Dexdor (T)
Dexmedetomidin
Dexmedetomidina
Dexmedetomidine
Dexmedetomidine (USAN/INN)
Dexmedetomidinum
Dexmédétomidine
MPV 1440
MPV-1440
Medetomidina [Spanish]
Medetomidine
Medetomidinum [Latin]
NCGC00025347-01
PRECEDEX
Precedex (TN)
Tocris-2023
ZINC04632106
7Adrenergic AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11535
8Analgesics, Non-NarcoticPhase 46260
9Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 117734
10Adrenergic beta-AntagonistsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 11154
11Antihypertensive AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 14095
12Autonomic AgentsPhase 4, Phase 3, Phase 29774
13Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 222776
14Adjuvants, AnesthesiaPhase 41588
15Anti-Arrhythmia AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 12969
16Adrenergic AgentsPhase 4, Phase 3, Phase 2, Phase 1, Early Phase 15140
17AnalgesicsPhase 411287
18Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210355
19Anesthetics, GeneralPhase 42787
20AnestheticsPhase 49001
21Analgesics, OpioidPhase 43091
22Anti-Inflammatory Agents, Non-SteroidalPhase 44295
23Anesthetics, IntravenousPhase 42406
24Cyclooxygenase InhibitorsPhase 42778
25NarcoticsPhase 43486
26Antirheumatic AgentsPhase 410627
27Cyclooxygenase 2 InhibitorsPhase 4616
28Central Nervous System DepressantsPhase 412806
29Prednisolone acetatePhase 4, Phase 3, Phase 21153
30Prednisolone hemisuccinatePhase 4, Phase 3, Phase 21153
31Adrenergic alpha-AgonistsPhase 41625
32Adrenergic AgonistsPhase 42877
33Prednisolone phosphatePhase 4, Phase 3, Phase 21153
34Protective AgentsPhase 4, Phase 3, Phase 27190
35Vasodilator AgentsPhase 4, Phase 2, Phase 3, Phase 13438
36AntiemeticsPhase 4, Phase 3, Phase 23888
37glucocorticoidsPhase 4, Phase 3, Phase 24920
38Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25407
39Neuroprotective AgentsPhase 4, Phase 3, Phase 21672
40Hormone AntagonistsPhase 4, Phase 3, Phase 212778
41Gastrointestinal AgentsPhase 4, Phase 3, Phase 28109
42Methylprednisolone acetatePhase 4, Phase 3, Phase 21153
43Methylprednisolone HemisuccinatePhase 4, Phase 3, Phase 21153
44HormonesPhase 4, Phase 3, Phase 213979
45Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 212767
46Hypnotics and SedativesPhase 42485
47Adrenergic alpha-2 Receptor AgonistsPhase 4911
48
PseudoephedrineapprovedPhase 360690-82-47028
Synonyms:
( )-Pseudoephedrine
(+) threo-2-(methylamino)-1-phenyl-1-propanol
(+)-(1S,2S)-Pseudoephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(1S,2S)-(+)-Pseudoephedrine
(1S,2S)-2-(methylamino)-1-phenylpropan-1-ol
(1S,2S)-2-Methylamino-1-phenyl-1-propanol
(1S,2S)-Pseudoephedrine
(1S,2S)-Pseudoephedrine, polymer-bound
1-Ephedrine
2-(Methylamino)-1-phenyl-1-propanol
287636_ALDRICH
304-87-0
30987-59-8
37577-31-4
649031_ALDRICH
90-82-4
AC-20292
AC1L1NUA
Acunaso
Acunaso (TN)
Afrinol
BIDD:GT0817
BRD-K84175871-003-02-2
BSPBio_003261
Balminil Decongestant Syrup
Benylin Decongestant
Benzenemethanol, alpha-((1S)-1-(methylamino)ethyl)-, (alpha-S)- (9CI)
Besan
C02765
C10H15NO
CHEBI:51209
CHEMBL1590
CID7028
CPD-9954
Cenafed
D-Isoephedrine
D-Pseudoephedrine
D-Pseudoephedrine base
D-Psi-2-Methylamino-1-phenyl-1-propanol
D-Psi-Ephedrine
D08449
DB00852
Decofed
Dimetapp Decongestant
Dimetapp Decongestant Pediatric Drops
DivK1c_000451
Drixoral N.D.
Drixoral Nasal Decongestant
EINECS 202-018-6
Efidac 24 Pseudoephedrine Hcl
Efidac/24
Eltor 120
Ephedrine
Genaphed
HSDB 3177
I01-8928
IDI1_000451
Isoephedrine
KBio1_000451
 
KBio2_001358
KBio2_003926
KBio2_006494
KBio3_002762
KBioGR_001763
KBioSS_001358
L(+)-Psi-Ephedrine
L(+)-psi-Ephedrine
L-(+)-Pseudoephedrine
LS-125922
Lopac-E-3250
Maxenal
MolPort-001-684-474
Myfedrine
NCGC00015408-01
NCGC00178180-01
NCI60_002955
NINDS_000451
Neodurasina
Neodurasina (TN)
Novafed
PDSP1_001347
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoefedrina [INN-Spanish]
Pseudoephedrine
Pseudoephedrine (D)
Pseudoephedrine (INN)
Pseudoephedrine D-form
Pseudoephedrine Ephedrine
Pseudoephedrine [INN:BAN]
Pseudoephedrine d-form
Pseudoephedrinum
Pseudoephedrinum [INN-Latin]
Psi-ephedrin
Psi-ephedrine
Robidrine
SPBio_001365
STOCK1N-42675
Spectrum2_001303
Spectrum3_001771
Spectrum4_001162
Spectrum5_000650
Spectrum_000878
Sudafed
Sudafed Decongestant
Sudafed Decongestant 12 Hour
Sudafed Decongestant Extra Strength
Triaminic AM Decongestant Formula
Triaminic Infant Oral Decongestant Drops
UNII-7CUC9DDI9F
alpha-(1-(Methylamino)ethyl)benzyl alcohol
d-Isoephedrine
d-Pseudoephedrine
d-psi-2-Methylamino-1-phenyl-1-propanol
d-psi-Ephedrine
pseudoéphédrine
trans-Ephedrine
ψ-ephedrine
49
EphedrineapprovedPhase 3606299-42-39294
Synonyms:
( )-Pseudoephedrine
(+)-Ephedrin
(+)-Ephedrine
(+)-Pseudoephedrine
(+)-psi-Ephedrine
(+)-threo-Ephedrine
(+-)-Ephedrine
(-)-Ephedrine
(-)-Pseudoephedrine
(-)-psi-Ephedrine
(-)-threo-Ephedrine
(1R,2R)-Ephedrine
(1R,2S)-1-Phenyl-1-hydroxy-2-methylaminopropane
(1S,2R)-Ephedrine
(L)-EPHEDRINE
--EPHEDRINE
1-EPHEDRINE
1-Sedrin
134910_ALDRICH
287636_ALDRICH
287644_ALDRICH
299-42-3
304-87-0
30987-59-8
321-96-0
321-97-1
321-98-2
37577-31-4
38732-95-5
45261_FLUKA
4607-45-8
50-98-6
50906-05-3
53214-57-6
649031_ALDRICH
6912-63-6
7009-81-6
90-82-4
968-63-8
AC-20231
AC-20292
AC1L1JGK
AC1L1NUA
AC1L1RFA
AC1L1SR1
AC1L1T31
AC1L1Y3M
AC1O8JUO
AC1Q3XJE
AC1Q3XJM
AC1Q3XJN
AC1Q59F5
AC1Q7701
AI3-02761
AKOS000268842
AR-1A0126
AR-1I7143
Acunaso
Acunaso (TN)
Afrinol
Ambap299-42-3
BIDD:GT0817
BRN 3197916
BRN 4231286
BSPBio_001946
BSPBio_001968
BSPBio_003261
Benylin Decongestant
Besan
Biophedrin
C01575
C02765
C10H15NO
CHEBI:15407
CHEBI:51209
CHEMBL1590
CHEMBL211456
CHEMBL357080
CID11972440
CID5032
CID62946
CID6710657
CID7028
CID8650
CID9294
CID9457
CPD-9954
CPDD 0049
Cenafed
D00124
D08449
DB00852
DB01364
Decofed
DivK1c_000181
DivK1c_000451
DivK1c_000461
Drixoral N.D.
EINECS 202-017-0
EINECS 202-018-6
EINECS 206-080-5
EINECS 206-292-8
EINECS 206-293-3
Eciphin
Efedrin
Efidac/24
Eltor 120
Ephedral
Ephedremal
Ephedrin
Ephedrine
Ephedrine (TN)
Ephedrine (USP)
Ephedrine [USAN:BAN]
Ephedrine l-form
Ephedrital
Ephedrol
Ephedrosan
Ephedrotal
Ephedsol
Ephendronal
Ephoxamin
Fedrin
Genaphed
HSDB 3072
HSDB 3177
I-Sedrin
I01-3584
I01-8925
I01-8928
 
IDI1_000181
IDI1_000451
IDI1_000461
Isoephedrine
Jsp005664
KBio1_000181
KBio1_000451
KBio1_000461
KBio2_001358
KBio2_001500
KBio2_003926
KBio2_004068
KBio2_006494
KBio2_006636
KBio3_001188
KBio3_001446
KBio3_002762
KBioGR_001013
KBioGR_001763
KBioSS_001358
KBioSS_001500
KST-1A9168
Kratedyn
L(+)-psi-Ephedrine
L(-)-Ephedrine
L-(+)-Ephedrine
L-(-)-Ephedrine
L-Ephedrine
L-erythro-2-(Methylamino)-1-phenylpropan-1-ol
L000968
LS-125921
LS-125922
LS-43083
LS-63961
LS-63962
LS-63963
LS-63964
Lexofedrin
Lopac-E-3250
Lopac0_000501
MLS000069657
Manadrin
Mandrin
Maxenal
MolPort-001-684-474
MolPort-001-684-477
MolPort-001-684-478
MolPort-001-684-479
MolPort-001-769-085
Myfedrine
NCGC00015408-01
NCGC00015408-02
NCGC00162174-01
NCGC00178180-01
NCGC00178889-01
NCI-C55652
NCI60_002955
NINDS_000181
NINDS_000451
NINDS_000461
NSC 165609
NSC 170951
NSC 8971
NSC165609
NSC170951
NSC8971
Nasol
Neodurasina
Neodurasina (TN)
Oprea1_287330
PDSP1_000168
PDSP1_001106
PDSP1_001343
PDSP1_001345
PDSP1_001346
PDSP1_001347
PDSP2_000167
PDSP2_001090
PDSP2_001327
PDSP2_001329
PDSP2_001330
PDSP2_001331
PSEUDOEPHEDRINE
Pedia Care
Pseudo
Pseudo 60's
Pseudo-12
Pseudoefedrina
Pseudoephedrine (D)
Pseudoephedrinum
Psi-ephedrin
Psi-ephedrine
Robidrine
SMR000059174
SPBio_000214
SPBio_001365
SPBio_001377
ST023802
STK367993
STOCK1N-42675
Sanedrine
Spectrum2_000137
Spectrum2_001303
Spectrum2_001309
Spectrum3_000414
Spectrum3_000563
Spectrum3_001771
Spectrum4_000497
Spectrum4_001162
Spectrum5_000650
Spectrum5_000879
Spectrum5_001106
Spectrum_000878
Spectrum_001020
Sudafed
Sudafed Decongestant
UNII-03VRY66076
UNII-7CUC9DDI9F
UNII-GN83C131XS
Vencipon
WLN: QYR & Y1 & M1
WLN: QYR&Y1&M1
Zephrol
d-Ephedrine
d-Isoephedrine
d-Pseudoephedrine
d-psi-Ephedrine
l-Ephedrine
l-Pseudoephedrine
racephedrine
trans-Ephedrine
50
TimololapprovedPhase 3, Phase 1, Phase 2, Early Phase 125226839-75-833624, 5478
Synonyms:
(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole
(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol
(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol
(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol
(S)-timolol
131628-37-0
194288-09-0
26839-75-8
26921-17-5 (maleate (1:1) salt)
AB00513729
AC1L1PYN
AC1Q59QM
Apo-Timol
Apo-Timop
Aquanil
BIDD:GT0073
BPBio1_001008
BRD-K08806317-050-03-6
BSPBio_000916
Betim
Betimol
Betimol (TN)
Blocadren
C07141
C13H24N4O3S
CAS-26921-17-5
CHEBI:9599
CHEMBL499
CID33624
CPD001456519
D08600
DB00373
DB08625
EINECS 248-032-6
HMS2089I11
HSDB 6533
Istalol
L-714,465
LS-122231
Lopac-T-6394
Lopac0_001189
MK-950
NCGC00016038-01
 
NCGC00016038-02
NCGC00016798-01
NCGC00016798-07
NCGC00022033-02
NCGC00022033-04
NCGC00022033-05
Novo-Timol
Nu-Timolol
Oprea1_640981
Optimol
Phoxal-timolol
Prestwick0_000948
Prestwick1_000948
Prestwick2_000948
Prestwick3_000948
Proflax
S(-)-Timolol maleate
S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole
SAM002564238
SPBio_003075
ST072193
TIM
Temserin
Tenopt
Tim-AK
Timacar
Timacor
Timolol
Timolol (INN)
Timolol (TN)
Timolol GFS
Timolol Maleate, (1:1) Salt
Timolol [USAN]
Timolol anhydrous
Timolol maleate
Timololo
Timololum
Timololum [INN-Latin]
Timopic
Timoptic
Timoptic OcuDose
Timoptic in Ocudose
Timoptic-XE
Timoptol
Tocris-0649
UNII-817W3C6175
timolol

Interventional clinical trials:

(show top 50)    (show all 172)
idNameStatusNCT IDPhase
1Role of Parecoxib Sodium for Postoperative Pain Management in Open HepatectomyUnknown statusNCT02204878Phase 4
2The Safety and Efficiency of Propranolol as an Initial Treatment for Pediatric HemangiomaCompletedNCT01908972Phase 4
3Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in NeurosurgeryRecruitingNCT02552459Phase 4
4Apollo™ Onyx™ Delivery Micro Catheter Post Market Safety StudyRecruitingNCT02378883Phase 4
5Stereotactic Body Radiotherapy for Spine TumorsActive, not recruitingNCT01347307Phase 4
6Visceral Artery Aneurysm Embolization by the Penumbra Ruby™ Coil SystemNot yet recruitingNCT02079818Phase 4
7Topical Timolol for Superficial Infantile HemangiomaUnknown statusNCT01685398Phase 3
8Treatment of Port Wine Stains in Children With Pulsed Dye Laser and Timolol GelUnknown statusNCT01272609Phase 3
9Functional Magnetic Resonance Imagine(fMRI)Navigation in Intracranial Arteriovenous Malformation SurgeryUnknown statusNCT01758211Phase 3
10Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2, Phase 3
11Pulse Steroids Versus Oral Steroids in Problematic Hemangiomas of InfancyCompletedNCT00312520Phase 3
12Evaluation of Vertebroplasty Associated With Radiotherapy for Spine Metastases (EVAR)CompletedNCT00267033Phase 3
13A Multicenter, Open-label Study for E7040 in Japanese Subjects With Hypervascular Tumor and Subjects With Arteriovenous MalformationCompletedNCT01677624Phase 3
14A Randomized Trial of Unruptured Brain AVMsCompletedNCT00389181Phase 3
15Nadolol Versus Propranolol in Children With Infantile HemangiomasRecruitingNCT02505971Phase 3
16CyberKnife Based Hypofractionated Radiotherapy for Vertebral HemangiomasRecruitingNCT02332408Phase 3
17Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile HemangiomaRecruitingNCT02342275Phase 3
18MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma PatientsNot yet recruitingNCT02962947Phase 2, Phase 3
19Propranolol in Capillary HemangiomasTerminatedNCT00744185Phase 2, Phase 3
20Efficacy and Safety of Propranolol Versus Acebutolol on the Proliferative Phase of Infantile HemangiomaTerminatedNCT01743885Phase 3
21Topical Timolol Gel for the Treatment of Infantile HemangiomasUnknown statusNCT02145884Phase 1, Phase 2
22Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot StudyUnknown statusNCT02317679Phase 2
23Nadolol for Proliferating Infantile HemangiomasCompletedNCT01010308Phase 2
24A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 2
25Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboCompletedNCT01512173Phase 2
26Comparative Study of the Use of Beta Blocker and Oral Corticosteroid in the Treatment of Infantile HemangiomaCompletedNCT01072045Phase 2
27Measurement Skin Temperature During Pulsed Laser ExposureCompletedNCT00540917Phase 2
28The Effects of Aldara as an Adjunct to Laser TreatmentCompletedNCT00979550Phase 2
29Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)CompletedNCT00857662Phase 2
30Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584CompletedNCT00052013Phase 2
31Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable MeningiomaCompletedNCT00589784Phase 2
32Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal BleedingCompletedNCT00389935Phase 2
33Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber SyndromeCompletedNCT02080624Phase 2
34Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaCompletedNCT01154452Phase 1, Phase 2
35Topical Timolol for Infantile Hemangioma in Early Proliferative PhaseRecruitingNCT02731287Phase 2
36A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular TumorsRecruitingNCT02110069Phase 2
37A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist RanibizumabRecruitingNCT02859441Phase 1, Phase 2
38Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO)RecruitingNCT02484716Phase 2
39Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous MalformationsRecruitingNCT02042326Phase 2
40Proton Radiotherapy for Primary Central Nervous System Tumours in AdultsRecruitingNCT02797366Phase 2
41Gemcitabine Hydrochloride With or Without Pazopanib Hydrochloride in Treating Patients With Refractory Soft Tissue SarcomaRecruitingNCT01532687Phase 2
42Trial to Evaluate the Safety of TTAC-0001 (Tanibirumab) in Recurrent GlioblastomaActive, not recruitingNCT03033524Phase 2
43Safety and Efficacy Study of Sirolimus in Complicated Vascular AnomaliesActive, not recruitingNCT00975819Phase 2
44Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber SyndromeActive, not recruitingNCT02332655Phase 1, Phase 2
45Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)Not yet recruitingNCT02913612Phase 2
46Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential TriaNot yet recruitingNCT02732678Phase 1, Phase 2
47Atorvastatin Therapy in Cerebral Cavernous Malformation: A Proof of Concept Phase I/II TrialNot yet recruitingNCT02603328Phase 1, Phase 2
48Propranolol Versus Prednisolone for Treatment of Symptomatic HemangiomasTerminatedNCT00967226Phase 2
49Clinical Trial of Vincristine vs. Prednisolone for Treatment of Complicated HemangiomasTerminatedNCT00555464Phase 2
50Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)TerminatedNCT01074437Phase 2

Search NIH Clinical Center for Hemangioma

Inferred drug relations via UMLS68/NDF-RT46:


Cochrane evidence based reviews: hemangioma

Genetic Tests for Hemangioma

About this section

Genetic tests related to Hemangioma:

id Genetic test Affiliating Genes
1 Hemangioma27

Anatomical Context for Hemangioma

About this section

MalaCards organs/tissues related to Hemangioma:

36
Liver, Endothelial, Lung, Brain, Skin, Bone, Thyroid

LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Hemangioma:
id TissueAnatomical CompartmentCell Relevance
1 HeartCardinal VeinsVenous Endothelial Cells Affected by disease

Publications for Hemangioma

About this section

Articles related to Hemangioma:

(show top 50)    (show all 2378)
idTitleAuthorsYear
1
Mixed Hemangioma of the Nasal Cavity Destructing the Nasal Bone. (28060104)
2017
2
Growing skull hemangioma: first and unique description in a patient with Klippel-TrAcnaunay-Weber syndrome. (27822901)
2017
3
Acquired hemangioma with features of Dabska tum or: an additional case. (27804154)
2017
4
Propranolol as First Line Treatment for Life-threatening Diffuse Infantile Hepatic Hemangioma: A Case Report. (28056491)
2017
5
A Case of Giant Intradural Extramedullary Capillary Hemangioma. (28091424)
2017
6
A case of diffuse cavernous hemangioma of the appendix: laparoscopic surgery can facilitate diagnosis and treatment. (28054281)
2017
7
Anastomosing Hemangioma of the Ovary: A Clinicopathological Study of Six Cases with Stromal Luteinization. (28050796)
2017
8
Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment. (27981617)
2017
9
Segmental hemangioma of the head and neck: High prevalence of PHACE syndrome. (28089002)
2017
10
Capillary hemangioma of the testis. A case report of a rare benign tumor. (27104006)
2016
11
Hepatic Hemangioma with Kasabach-Merritt Syndrome in an Adult Patient. (27112250)
2016
12
Multiparametric sonographic imaging of a capillary hemangioma of the testis: appearances on gray-scale, color Doppler, contrast-enhanced ultrasound and strain elastography. (26941881)
2016
13
Misdiagnosis of pathological femoral fracture in a patient with intramuscular hemangioma: A case report. (27347124)
2016
14
Solitary Pulmonary Capillary Hemangioma of Adult Cases: Clinicopathologic Characteristics as an Unrecognized Entity. (27454944)
2016
15
Resection of Giant Hemangioma of the Tongue Utilizing a Miniature Tourniquet Technique. (27391511)
2016
16
A case report of spondylectomy with circumference reconstruction for aggressive vertebral hemangioma covering the whole cervical spine (C4) with progressive spinal disorder. (27613010)
2016
17
Hobnail Hemangioma With an Unusual Clinical Presentation: Case Report. (27708135)
2016
18
Capillary hemangioma or pyogenic granuloma. (27041829)
2016
19
Intraosseous Cellular Hemangioma of the Orbit: A Rare Subtype. (27107355)
2016
20
Large benign de novo conjunctival hemangioma in an 11-year-old boy: case report and literature review. (27647119)
2016
21
Cavernous hemangioma in unusual location: pterygopalatine fossa. (27117893)
2016
22
A case of giant fetal intracranial capillary hemangioma cured with propranolol. (26824594)
2016
23
Intradural Extramedullary Capillary Hemangioma in the Upper Cervical Spine: First Report. (27185649)
2016
24
Sclerosing hemangioma: A diagnostic dilemma in fine needle aspiration cytology. (27168758)
2016
25
Calvarial bone cavernous hemangioma with intradural invasion: An unusual aggressive course-Case report and literature review. (27061482)
2016
26
Cavernous hemangioma of the submandibular gland with parapharyngeal extension in an adult: Case report. (26930336)
2016
27
Intravitreal bevacizumab and feeder vessel laser treatment for a posteriorly located retinal capillary hemangioma. (26815929)
2016
28
Jagged1/Notch3 Signaling Modulates Hemangioma-Derived Pericyte Proliferation and Maturation. (27941324)
2016
29
Pleural effusion caused by a capillary hemangioma in the pleural cavity. (27087237)
2016
30
Postictal Prosopometamorphopsia after Focal Status Epilepticus due to Cavernous Hemangioma in the Right Occipital Lobe. (27095527)
2016
31
Extra-axial dural cavernous hemangioma with dural tail sign, masquerading as meningioma. (27695257)
2016
32
Enucleation is Better for a Giant Hemangioma Proximal to the Hepatic Portal Vascular Structures. (27574349)
2016
33
Diffuse Cavernous Hemangioma of the Colon. (27821043)
2016
34
CAVERNOUS HEMANGIOMA OF THE RETINA: A Comprehensive Review of the Literature (1934-2015). (27820777)
2016
35
Prenatal diagnosis of thrombosed dural sinus malformation with periorbital hemangioma: a case report. (26603566)
2016
36
Multiple Successful Angioembolizations for Refractory Cardiac Failure in a Preterm with Rapidly Involuting Congenital Hemangioma. (26929881)
2016
37
Improved Vision from Severe Compressive Optic Neuropathy by Apical Cavernous Hemangioma. (27099610)
2016
38
Multifocal spindle cell hemangioma: Report of two cases. (26728826)
2016
39
Pure laparoscopic right hepatectomy for giant hemangioma using anterior approach. (27620909)
2016
40
Spectral-Domain Optical Coherence Tomography Findings in Cavernous Hemangioma of the Optic Disk. (27552290)
2016
41
EP10.01: Isolated fetal neck hemangioma mimicking thyroid. (27644985)
2016
42
Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE). (27114263)
2016
43
Lobular Capillary Hemangioma ("Pyogenic Granuloma") of the Trachea. (27014842)
2016
44
Multiple glomeruloid hemangiomas without POEMS syndrome. (27126256)
2016
45
Whole-exome sequencing identifies recurrent AKT1 mutations in sclerosing hemangioma of lung. (27601661)
2016
46
A very rare cause of abdominal pain in a male adolescent: cavernous hemangioma. (27599403)
2016
47
Intramuscular hemangioma of the masseter muscle- a case report and review of literature. (27518245)
2016
48
Verrucous Hemangioma or Verrucous Venous Malformation? Towards a Classification Based on Genetic Analysis. (26703822)
2016
49
Coexistence of splenic hemangioma and vascular malformation of the vertebrae. (26860733)
2016
50
Extramedullary Cavernous Hemangioma with Intradural and Extradural Growth and Clinical Symptoms of Brown-SAcquard Syndrome: Case Report and Review of the Literature. (27867117)
2016

Variations for Hemangioma

About this section

Expression for genes affiliated with Hemangioma

About this section
Search GEO for disease gene expression data for Hemangioma.

Pathways for genes affiliated with Hemangioma

About this section

Pathways related to Hemangioma according to GeneCards Suite gene sharing:

(show all 25)
idSuper pathwaysScoreTop Affiliating Genes
1
Show member pathways
9.9FLT4, KDR, VEGFA
2
Show member pathways
9.9FLT4, KDR, VEGFA
39.9FGF2, KDR, VEGFA
49.9FGF2, KDR, VEGFA
5
Show member pathways
9.9FLT4, KDR, KRAS
69.8FGF2, SLC2A1, VEGFA
79.7ACTC1, FGF2, KDR
89.7FGF2, FLT4, KDR, VEGFA
9
Show member pathways
9.7FLT4, KDR, KRAS, VEGFA
109.6FGF2, KDR, PROX1, VEGFA
119.6FGF2, KDR, KRAS, VEGFA
129.6ANGPT1, TEK, VEGFA
13
Show member pathways
9.6FLT4, KDR, KRAS, TEK
149.4FGF2, FLT4, KDR, KRAS, VEGFA
159.3ANGPT2, FGF2, FLT4, KDR, TEK
16
Show member pathways
9.3ANGPT1, ANGPT2, FGF2, TEK
17
Show member pathways
9.2ANGPT1, FGF2, KDR, TEK, VEGFA
189.1ANGPT1, ANGPT2, SLC2A1, TEK, VEGFA
19
Show member pathways
8.9ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
20
Show member pathways
8.9ANGPT1, ANGPT2, KRAS, PECAM1, TEK
21
Show member pathways
8.7ANGPT2, FGF2, FLT4, KDR, PECAM1, PROX1
22
Show member pathways
8.5ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
238.5ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
24
Show member pathways
8.4ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS
25
Show member pathways
8.1ANGPT1, ANGPT2, FGF2, FLT4, KDR, KRAS

GO Terms for genes affiliated with Hemangioma

About this section

Cellular components related to Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1membrane raftGO:00451219.6ANGPT1, KDR, KRAS, PECAM1, SLC2A1, TEK
2cell peripheryGO:00719449.6CD34, LYVE1, PECAM1
3extracellular spaceGO:00056158.8ACTC1, ANGPT1, ANGPT2, FGF2, KRIT1, PECAM1
4extracellular regionGO:00055768.7ANGPT1, ANGPT2, CD34, FGF2, FLT4, KDR
5plasma membraneGO:00058865.3ANGPT1, ANGPT2, ANTXR1, CD34, DIO3, FLT4

Biological processes related to Hemangioma according to GeneCards Suite gene sharing:

(show all 42)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathwayGO:003803310.9KDR, VEGFA
2positive regulation of positive chemotaxisGO:005092710.9KDR, VEGFA
3positive regulation of protein kinase C signalingGO:009003710.8FLT4, VEGFA
4lymph vessel developmentGO:000194510.8FLT4, PROX1
5negative regulation of blood vessel endothelial cell migrationGO:004353710.7ANGPT2, FGF2
6cellular response to vascular endothelial growth factor stimulusGO:003592410.7FLT4, KDR, VEGFA
7cell migration involved in sprouting angiogenesisGO:000204210.7FGF2, KDR, VEGFA
8positive regulation of focal adhesion assemblyGO:005189410.6KDR, TEK, VEGFA
9positive regulation of cellular component movementGO:005127210.6PDPN, VEGFA
10endothelium developmentGO:000315810.6CD34, KDR
11glomerulus vasculature developmentGO:007201210.6ANGPT1, ANGPT2
12positive regulation of MAP kinase activityGO:004340610.6FGF2, KRAS, VEGFA
13positive regulation of vasculogenesisGO:200121410.5CD34, KDR
14skeletal muscle thin filament assemblyGO:003024010.5ACTC1, PROX1
15endothelial cell proliferationGO:000193510.5CD34, TEK
16positive chemotaxisGO:005091810.4ANGPT1, FGF2, VEGFA
17positive regulation of blood vessel endothelial cell migrationGO:004353610.4ANGPT1, FGF2, VEGFA
18peptidyl-tyrosine phosphorylationGO:001810810.4FGF2, FLT4, KDR, TEK
19lymphangiogenesisGO:000194610.4FLT4, PDPN, PROX1
20glomerular endothelium developmentGO:007201110.4CD34, PECAM1
21negative regulation of angiogenesisGO:001652510.4ANGPT2, KRIT1, TEK
22positive regulation of phosphatidylinositol 3-kinase signalingGO:001406810.4ANGPT1, KDR, TEK
23positive regulation of protein kinase B signalingGO:005189710.3ANGPT1, FGF2, TEK
24hyaluronan catabolic processGO:003021410.2FGF2, LYVE1
25sprouting angiogenesisGO:000204010.2ANGPT1, FLT4, TEK
26MAPK cascadeGO:000016510.1ANGPT1, FGF2, KRAS, TEK
27negative regulation of endothelial cell apoptotic processGO:200035210.1ANGPT1, KDR, KRIT1, TEK
28Tie signaling pathwayGO:004801410.1ANGPT1, ANGPT2, TEK
29positive regulation of ERK1 and ERK2 cascadeGO:007037410.0ANGPT1, FGF2, FLT4, KDR, TEK
30positive regulation of cell proliferationGO:000828410.0FGF2, FLT4, KDR, KRAS, PROX1, VEGFA
31positive regulation of endothelial cell proliferationGO:00019389.9FGF2, FLT4, KDR, PROX1, TEK, VEGFA
32lung developmentGO:00303249.9FGF2, NKX2-1, PDPN, PROX1, VEGFA
33transmembrane receptor protein tyrosine kinase signaling pathwayGO:00071699.9ANGPT1, FLT4, KDR, TEK
34vascular endothelial growth factor receptor signaling pathwayGO:00480109.9FLT4, KDR, VEGFA
35positive regulation of protein phosphorylationGO:00019349.9FGF2, FLT4, KDR, KRAS, TEK, VEGFA
36negative regulation of apoptotic processGO:00430669.7ACTC1, ANGPT1, FLT4, KDR, TEK, VEGFA
37positive regulation of angiogenesisGO:00457669.6ANGPT2, CD34, FGF2, KDR, TEK, VEGFA
38positive regulation of endothelial cell migrationGO:00105959.5ANGPT1, FGF2, FLT4, KDR, PROX1, TEK
39positive regulation of gene expressionGO:00106289.5ACTC1, CD34, FGF2, KRAS, NKX2-1, VEGFA
40angiogenesisGO:00015259.4ANGPT1, ANGPT2, FGF2, KDR, KRIT1, TEK
41leukocyte migrationGO:00509009.1ANGPT1, ANGPT2, CD34, KRAS, PECAM1, TEK
42signal transductionGO:00071657.9ANGPT2, ANTXR1, CD34, FGF2, LYVE1, PDPN

Molecular functions related to Hemangioma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1growth factor bindingGO:001983810.3FLT4, KDR, TEK
2vascular endothelial growth factor-activated receptor activityGO:000502110.1FLT4, KDR
3transmembrane receptor protein tyrosine kinase activityGO:000471410.0FLT4, KDR, TEK

Sources for Hemangioma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet